US 8298541
Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae
granted A61KA61K2039/5252A61K2039/5254
Quick answer
US patent 8298541 (Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/5252, A61K2039/5254, A61K39/00, A61K39/12